About i-SENS
i-SENS is a company based in Zhangjiagang (China) founded in 2000. The company has 81 employees as of April 03, 2024. i-SENS offers products and services including CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care. i-SENS operates in a competitive market with competitors including Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others.
- Headquarter Zhangjiagang, China
- Employees 81 as on 03 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Isens Biosensors India Private Limited
- Date of Incorporation 27 Mar, 2015
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$3.87 M (USD)6.52as on Mar 31, 2023
-
Net Profit
$368.23 K (USD)3.29as on Mar 31, 2023
-
EBITDA
$122.37 K (USD)-70.33as on Mar 31, 2023
-
Latest Funding Round
$149.9 K (USD), Grant
Aug 05, 2014
- Investors
-
Employee Count
81
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of i-SENS
i-SENS offers a comprehensive portfolio of products and services, including CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care.
App for real-time glucose tracking and data sharing.
Devices for measuring blood sugar levels accurately.
System for ongoing glucose level tracking.
Tools for immediate diagnostic testing.
Products for glucose monitoring in animals.
People of i-SENS
Unlock access to complete
Unlock access to complete
Funding Insights of i-SENS
Investors in i-SENS
i-SENS has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for i-SENS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by i-SENS
Investment portfolio details for i-SENS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - i-SENS
Detailed financials for i-SENS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
I-Sens Comparisons
Peer comparison for i-SENS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of i-SENS
i-SENS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
|
| Locked | Locked | Locked |
Diabetes is managed via cellular technology and social networking.
|
|
| Locked | Locked | Locked |
An all-in-one blood glucose monitoring system is developed and offered.
|
|
| Locked | Locked | Locked |
Insulin dosage guidance for diabetes is provided via handheld devices.
|
|
| Locked | Locked | Locked |
Provides blood glucose monitoring systems and diabetes care solutions worldwide.
|
|
| Locked | Locked | Locked |
Manufacturer and Global seller of Blood glucose monitoring systems
|
Detailed competitors of i-SENS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on I-Sens
Complete news archive for i-SENS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about i-SENS
i-SENS was founded in 2000 and raised its 1st funding round 14 years after it was founded.
i-SENS is headquartered in Zhangjiagang, China. It is registered at Zhangjiagang, Jiangsu, China.
As of Apr 03, 2024, the latest employee count at i-SENS is 81.
Annual revenue of i-SENS is $3.87M as on Mar 31, 2023.
i-SENS was founded in 2000 and is based in Zhangjiagang, China. Blood glucose monitoring systems, such as the CareSens model for sugar level detection, and clinical chemistry analyzers are produced by the company. A mobile application is provided for users to record and review blood glucose data. Operations center on diagnostic tools within the healthcare sector.
i-SENS's top competitors include Telcare, Jana Care and Intuity Medical.
i-SENS offers CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care.
i-SENS has 1 investor. Key investors include HHS.